Showing results (1731-1740 of 2,433) with videos related to
Sort By:
Pageof 244
Japanese Journal of Clinical Oncology|October 1, 1995
Intensive chemotherapy with cisplatin, doxorubicin, cyclophosphamide, etoposide and granulocyte colony-stimulating factor for advanced thymoma or thymic cancer: preliminary resultsF Oshita, T Kasai, T Kurata, et al.Therapeutic Drug Monitoring|June 1, 1995
Efficient sampling strategies for forecasting pharmacokinetic parameters of irinotecan (CPT-11): implication for area under the concentration-time curve monitoringH Nakashima, R Lieberman, A Karato, et al.The Journal of Sports Medicine and Physical Fitness|March 1, 1993
Triathlon competition induced a transient immunosuppressive change in the peripheral blood of athletesS Shinkai, Y Kurokawa, S Hino, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993
Phase I study of CPT-11 and etoposide in patients with refractory solid tumorsA Karato, Y Sasaki, T Shinkai, et al.Clinical & Experimental Metastasis|October 31, 1997
Inhibition by ginsenoside Rg3 of bombesin-enhanced peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in Wistar ratsH Iishi, M Tatsuta, M Baba, et al.Journal of Aging and Health|April 24, 2015
Cardiometabolic Risk, Socio-Psychological Factors, and Trajectory of Grip Strength Among Older Japanese AdultsAnda Botoseneanu, Joan M Bennett, Linda Nyquist, et al.Gan|November 1, 1984
Correlation between drug sensitivity determined by clonogenic cell assay and clinical effect of chemotherapy in patients with primary lung cancerE Shimizu, N Saijo, F Kanzawa, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1992
Chemotherapy-induced anemia in patients with primary lung cancerH Okamoto, N Saijo, T Shinkai, et al.Cancer Chemotherapy and Pharmacology|January 1, 1992
A prognostic-factor risk index in advanced non-small-cell lung cancer treated with cisplatin-containing combination chemotherapyT Shinkai, K Eguchi, Y Sasaki, et al.Cancer|February 1, 1992
Alternating non-cross-resistant chemotherapy for non-Hodgkin's lymphoma of intermediate-grade and high-grade malignancy. A pilot studyM Hirano, M Okamoto, F Maruyama, et al.Pageof 244